A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Esaote North America Announces a NEW Addition to its Veterinary Ultrasound Portfolio

Esaote North America announces the addition of a new dedicated veterinary ultrasound product available for purchase in the USA, the MyLab™X75VET ultrasound system. The MyLab™X75VET is equipped with Esaote’s dedicated veterinary software and probes to address the demanding imaging needs of a wide range of veterinary applications.

This versatile console is ergonomically designed and offers premium cardiac imaging and an advanced measurement package. Additional features include:

  • Dedicated Veterinary software and probes – up to 22MHz
  • Workflow enhancements like easyMode, easyColor, and eScan
  • Optimized cardiac imaging
  • Integrated battery and Connectivity

Esaote North America is internationally recognized as a leader in providing superior Ultrasound solutions and Dedicated MRI systems. The latest portfolio of Ultrasound systems and MRI platforms are built on a Windows® 10 operating system for optimal security and equipped with advanced workflow enhancements to help users optimize workflow and increase efficiency.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy